Iterum Therapeutics plc (ITRM) Free Cash Flow by Year
Iterum Therapeutics plc recorded an outflow of $26.8M in free cash flow in fiscal year 2024. This represents an increase of 32.0% from the prior fiscal year. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to an outflow of $19.5M in free cash flow. The table below carries 9 fiscal years, from 2016 to 2024, and the quarters Iterum Therapeutics plc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ITRM Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2410-Q | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -$19.5M | -$26.8M+32.0% | -$39.3M-112.3% | -$18.5M-16.6% | -$15.9M+70.8% | -$54.5M+33.4% | -$81.9M-6.0% | -$77.3M-146.2% | -$31.4M | N/A |
TTM is the trailing twelve months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
ITRM Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Iterum Therapeutics plc financials
Frequently Asked Questions
What was Iterum Therapeutics plc's free cash flow in fiscal year 2024?
Iterum Therapeutics plc recorded an outflow of $26.8M in free cash flow in fiscal year 2024.
How fast is Iterum Therapeutics plc's free cash flow growing?
Iterum Therapeutics plc (ITRM) free cash flow rose by 32.0% year over year, from -$39.3M to -$26.8M in fiscal year 2024.
What is Iterum Therapeutics plc's free cash flow over the last twelve months?
Iterum Therapeutics plc (ITRM) reported an outflow of $19.5M in free cash flow over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
What was Iterum Therapeutics plc's free cash flow in the most recent quarter?
Iterum Therapeutics plc (ITRM) reported -$7.5M in free cash flow in Q3 2025. This represents a decrease of 179.2% from the same quarter a year earlier.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Iterum Therapeutics plc (ITRM) reported on that line in every period on record.